These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37132539)

  • 1. Marketing pitches of 'magic mushrooms' and 'psychedelics' mask that psychotomimetics use exposes those vulnerable to serious adverse effects.
    Braillon A; Naudet F
    J Psychopharmacol; 2023 Jul; 37(7):749-750. PubMed ID: 37132539
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Marketing pitches of 'magic mushrooms' and 'psychedelics' mask that psychotomimetics use exposes those vulnerable to serious adverse effects.
    Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J
    J Psychopharmacol; 2023 Jul; 37(7):750-751. PubMed ID: 37439350
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: Marketing pitches of 'magic mushrooms' and 'psychedelics' mask that psychotomimetics use exposes those vulnerable to serious adverse effects.
    Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J
    J Psychopharmacol; 2023 May; ():2698811231169641. PubMed ID: 37132540
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.
    Kopra EI; Ferris JA; Winstock AR; Young AH; Rucker JJ
    J Psychopharmacol; 2022 Aug; 36(8):965-973. PubMed ID: 35388724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.
    Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J
    J Psychopharmacol; 2023 Jan; 37(1):49-60. PubMed ID: 36515370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freaky fungi in Japan. Authorities are tripped up by 'magic mushrooms'.
    Hadfield P
    US News World Rep; 2001 Aug; 131(5):27. PubMed ID: 11499368
    [No Abstract]   [Full Text] [Related]  

  • 8. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
    Musshoff F; Madea B; Beike J
    Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.
    Meyer TD; Meir P; Lex C; Soares JC
    Psychiatry Res; 2022 Oct; 316():114727. PubMed ID: 35878481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hallucinogenic mushrooms].
    Reingardiene D; Vilcinskaite J; Lazauskas R
    Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychoactive mushrooms - an update].
    Supprian T; Frey U; Supprian R; Rösler M; Wanke K
    Fortschr Neurol Psychiatr; 2001 Dec; 69(12):597-602. PubMed ID: 11753749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Automutilation after consumption of hallucinogenic mushrooms].
    Attema-de Jonge ME; Portier CB; Franssen EJ
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury-Triggered Blueing Reactions of Psilocybe "Magic" Mushrooms.
    Lenz C; Wick J; Braga D; García-Altares M; Lackner G; Hertweck C; Gressler M; Hoffmeister D
    Angew Chem Int Ed Engl; 2020 Jan; 59(4):1450-1454. PubMed ID: 31725937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.
    Barrett FS; Bradstreet MP; Leoutsakos JS; Johnson MW; Griffiths RR
    J Psychopharmacol; 2016 Dec; 30(12):1279-1295. PubMed ID: 27856683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of psilocybin.
    Passie T; Seifert J; Schneider U; Emrich HM
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region].
    Maruyama T; Shirota O; Kawahara N; Yokoyama K; Makino Y; Goda Y
    Shokuhin Eiseigaku Zasshi; 2003 Feb; 44(1):44-8. PubMed ID: 12749196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.
    Fitzpatrick CM; Anderson BT; Agin-Liebes G; Guydish J
    J Psychoactive Drugs; 2022; 54(4):324-327. PubMed ID: 35083957
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm potential of magic mushroom use: a review.
    van Amsterdam J; Opperhuizen A; van den Brink W
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):423-9. PubMed ID: 21256914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.